Global medical solutions group Convatec (CTEC) said it has made a good start to the 2022 financial year with organic revenues up 6% year-on-year. Despite raising guidance on cost inflation to between 8% and 9% compared with 5% previously, the company reiterated full-year guidance. That is, organic revenues are anticipated to grow between 4% and 5% with an operating margin of at least ...

The transformation of medical technology company ConvaTec (CTEC) has reached an inflection point which should drive market-beating sales growth and improve profitability. The shares look attractive against good earnings potential while scope for the stock to trade on a higher multiple of earnings (known as a ‘re-rating’) provides extra attractions. This could be driven by a modest ...

Wound Care and medical solutions firm ConvaTec (CTEC) has agreed to acquire Triad Life Sciences Inc for an initial $125 million, strengthening the company’s US Advanced Wound Care business. Investors gave the acquisition a warm reception, marking the shares up 1.3% to 170.2p. ConvaTec said the deal gives it entry into the large and fast-growing biologics segment of the wound care market ...

Constructed last December from shares in UK, European and US markets, Shares’ ‘Stock picks for 2021’ portfolio was based on high conviction in 12 companies for the year ahead. While more than half of them have subsequently done well, there were a handful of disappointments. The net effect is a decent 8.6% return excluding dividends – that’s higher the historical average 6% to ...

There is no reason why a share must open at the previous night’s closing price. Daily price moves are determined by supply and demand for the shares and that in turn is affected by company news such as earnings updates, acquisitions, disposals, legal disputes, new product launches and so on. In fact anything which changes the fundamentals or investor sentiment towards a company has the ...

Shares in medical products company ConvaTec (CTEC) jumped 5% to 208p after it increased full-year guidance for organic revenue growth towards the top end of its 3.5%-to-5% range. After a strong first half which saw 7.5% organic growth, third quarter revenues through September grew 3.7% year-on-year to $511 million, up 2.7% in constant currencies and 2.2% on an organic basis. Performance was ...

UK stocks retreated in early trading with just half a dozen FTSE names trading up on last night’s close heading into the weekend. At 8.30am the benchmark was 26 points or 0.35% lower at 7,223 points, almost exactly where it closed on Monday. Overnight, US markets ended at record highs but weak earnings from tech giants Amazon and Apple after the close sent index futures lower signalling a ...

Convatec (CTEC) 225.6p Gain to date 10.2% Original entry point: Buy at 204.6p on 23 December 2020 Shares in medical products company Convatec (CTEC) have dropped approximately 13% since reporting stronger than expected first half growth and lifting guidance for full year organic revenue growth. The share price reaction can be attributed to adjusted operating margin guidance being ...

UK stocks finished the month flat despite a strong corporate  earnings season as concerns over Chinese regulation of technology stocks and disappointing US results weighed on sentiment. Overnight, Asian stocks sank as fears re-surfaced that Beijing could extend its intervention to more parts of the Chinese economy, while in the US shares in e-commerce giant Amazon.com fell 7% after the ...

UK stocks traded lower at lunchtime on Friday after continued weak trading in Asia and as e-commerce giant Amazon missed quarterly sales forecasts for the first time since 2018, sending its shares down 7% in after-hours trading. Japan’s Nikkei 225 index sank 1.8% while China’s SE Composite gave up 0.4% as concerns increased over the tighter regulation of Chinese companies. Brent Crude ...

Shares in medical products company ConvaTec (CTEC) fell 5.9% to 244.6p on Friday despite reported stronger than expected first half growth after it warned of notably higher expected cost inflation in the second half. Constant currency full year adjusted operating margins are now expected to be between 18% and 19%, from the previously guided 18% to 19.5%, excluding currency movements. The ...

UK stocks opened lower on Friday after continued weak trading in Asia and as e-commerce giant Amazon missed quarterly sales forecasts for the first time since 2018, sending its shares down 7% in after-hours trading. Japan’s Nikkei 225 index sank 1.8% while China’s SE Composite gave up 0.4%. Brent Crude prices fell 0.5% to $73.2 per barrel and Gold was flat at $1,829 per ounce. At 9am ...

A key theme in the UK market in 2021 has been a spate of takeovers, mergers and strategic deals involving British businesses as buyers, often from overseas, have been attracted by lowly valuations relative to other international equities. By the reckoning of stockbroker Peel Hunt, nearly £25 billion worth of bids for more than 20 companies have been pitched in the last six months and ...

Every December Shares selects a group of stocks to own for the year ahead. The selection for 2021 have performed well with an average share price gain of 15.2% over the past six months compared with a return of 11.9% for the FTSE-All Share index. Although the list isn’t intended to be a portfolio, to calculate the return we have assumed that each holding has an equal weighting. The ...

ConvaTec (CTEC) 223.8p Gain to date: 9.3% Original entry point: Buy at 204.6p, 23 December 2020 Shares in medical products firm Convatec (CTEC) are finally picking up, having been a laggard earlier this year thanks to a mix of sentiment shifting in favour of value stocks and concerns around pandemic-related disruption to the business. Its latest update (29 Apr) seems to have won ...

Investors spent 2020 worrying about Covid-19 but as vaccines rollout and economies begin to gradually reopen, equity markets are getting increasingly jumpy about a new threat - inflation. Investors should not treat these warnings lightly. The most obvious response to rising inflation for central banks (the Bank of England  in our case) is to reverse  ‘lower for longer’ interest rate ...

At the end of a tumultuous first quarter for global markets our top picks for 2021 have handily outperformed the market, chalking up a 9.5% gain versus 6.3% from UK shares in general, as measured by the FTSE All-Share. Four of the 12 stocks have underperformed, having been victims of shifting market sentiment as much as any individual failings at a        company-level. BUMPER ...

Shares in medical products company ConvaTec (CTEC) gained 3% to 195p on Friday after reporting a resilient full year performance and providing a better than expected outlook. The company, which has seen demand pressure as elective procedures were delayed because of Covid, said it expected to deliver organic revenue growth of between 3% to 4.5% and a constant currency adjusted EBIT margin ...

UK stocks headed into the weekend on a decidedly down note after US markets fell for a third day on Thursday. The Nasdaq 100 index is already down on the year and back to November levels while S&P 500 is barely in positive territory. The FTSE 100 index dropped by 60 points or 0.8% to 6,590 in the first half hour of trading with financial stocks and miners bearing the brunt of the ...

After recently upgrading (28 October) full-year revenue growth to the top of its 2% to 3.5% target range, medical products company ConvaTec (CTEC) looks well placed going into 2021 as several tailwinds form. A faster than anticipated recovery in US elective surgeries is providing a boost for its wound care business and new product launches position the company for renewed ...